These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
373 related items for PubMed ID: 31501002
1. TNF-α and IL-17A induce the expression of lympho-epithelial Kazal-type inhibitor in epidermal keratinocytes. Sugihara S, Sugimoto S, Tachibana K, Kobashi M, Nomura H, Miyake T, Hirai Y, Yamasaki O, Morizane S. J Dermatol Sci; 2019 Oct; 96(1):26-32. PubMed ID: 31501002 [Abstract] [Full Text] [Related]
2. Toll-like receptor signaling induces the expression of lympho-epithelial Kazal-type inhibitor in epidermal keratinocytes. Sugimoto S, Morizane S, Nomura H, Kobashi M, Sugihara S, Iwatsuki K. J Dermatol Sci; 2018 Nov; 92(2):181-187. PubMed ID: 30270115 [Abstract] [Full Text] [Related]
3. Expression of serine protease inhibitors in epidermal keratinocytes is increased by calcium but not 1,25-dihydroxyvitamin D3 or retinoic acid. Kobashi M, Morizane S, Sugimoto S, Sugihara S, Iwatsuki K. Br J Dermatol; 2017 Jun; 176(6):1525-1532. PubMed ID: 27797397 [Abstract] [Full Text] [Related]
4. Physiological and pathological roles of kallikrein-related peptidases in the epidermis. Kishibe M. J Dermatol Sci; 2019 Aug; 95(2):50-55. PubMed ID: 31279501 [Abstract] [Full Text] [Related]
5. Exonic mutations associated with atopic dermatitis disrupt lympho-epithelial Kazal-type related inhibitor action and enhance its degradation. Ramesh K, Matta SA, Chew FT, Mok YK. Allergy; 2020 Feb; 75(2):403-411. PubMed ID: 31407378 [Abstract] [Full Text] [Related]
6. Identification of lympho-epithelial Kazal-type inhibitor 2 in human skin as a kallikrein-related peptidase 5-specific protease inhibitor. Meyer-Hoffert U, Wu Z, Schröder JM. PLoS One; 2009 Feb; 4(2):e4372. PubMed ID: 19190773 [Abstract] [Full Text] [Related]
7. Multifaceted Analyses of Epidermal Serine Protease Activity in Patients with Atopic Dermatitis. Nomura H, Suganuma M, Takeichi T, Kono M, Isokane Y, Sunagawa K, Kobashi M, Sugihara S, Kajita A, Miyake T, Hirai Y, Yamasaki O, Akiyama M, Morizane S. Int J Mol Sci; 2020 Jan 30; 21(3):. PubMed ID: 32019242 [Abstract] [Full Text] [Related]
10. Complementary effect of hydroquinone and retinoic acid on corneocyte desquamation with their combination use. Cheong KA, Lee TR, Lee AY. J Dermatol Sci; 2017 Aug 30; 87(2):192-200. PubMed ID: 28433430 [Abstract] [Full Text] [Related]
11. Suppression of IL-17A-induced CCL20 production by cytokine inducible SH2-containing protein 1 in epidermal keratinocytes. Tohyama M, Matsumoto A, Tsuda T, Dai X, Shiraishi K, Sayama K. J Dermatol Sci; 2021 Mar 30; 101(3):202-209. PubMed ID: 33509657 [Abstract] [Full Text] [Related]
12. T Helper 1 and T Helper 2 Cytokines Differentially Modulate Expression of Filaggrin and its Processing Proteases in Human Keratinocytes. Di ZH, Ma L, Qi RQ, Sun XD, Huo W, Zhang L, Lyu YN, Hong YX, Chen HD, Gao XH. Chin Med J (Engl); 2016 Feb 05; 129(3):295-303. PubMed ID: 26831231 [Abstract] [Full Text] [Related]
13. Interleukin-17A-induced production of acute serum amyloid A by keratinocytes contributes to psoriasis pathogenesis. Couderc E, Morel F, Levillain P, Buffière-Morgado A, Camus M, Paquier C, Bodet C, Jégou JF, Pohin M, Favot L, Garcia M, Huguier V, Mcheik J, Lacombe C, Yssel H, Guillet G, Bernard FX, Lecron JC. PLoS One; 2017 Feb 05; 12(7):e0181486. PubMed ID: 28708859 [Abstract] [Full Text] [Related]
14. Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome. Briot A, Deraison C, Lacroix M, Bonnart C, Robin A, Besson C, Dubus P, Hovnanian A. J Exp Med; 2009 May 11; 206(5):1135-47. PubMed ID: 19414552 [Abstract] [Full Text] [Related]
15. A proinflammatory role of KLK6 protease in Netherton syndrome. Zingkou E, Pampalakis G, Charla E, Nauroy P, Kiritsi D, Sotiropoulou G. J Dermatol Sci; 2019 Jul 11; 95(1):28-35. PubMed ID: 31255470 [Abstract] [Full Text] [Related]
16. Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation. Johnston A, Fritz Y, Dawes SM, Diaconu D, Al-Attar PM, Guzman AM, Chen CS, Fu W, Gudjonsson JE, McCormick TS, Ward NL. J Immunol; 2013 Mar 01; 190(5):2252-62. PubMed ID: 23359500 [Abstract] [Full Text] [Related]
17. Involvement of IL-17F via the induction of IL-6 in psoriasis. Fujishima S, Watanabe H, Kawaguchi M, Suzuki T, Matsukura S, Homma T, Howell BG, Hizawa N, Mitsuya T, Huang SK, Iijima M. Arch Dermatol Res; 2010 Sep 01; 302(7):499-505. PubMed ID: 20148256 [Abstract] [Full Text] [Related]
18. IL-36γ sustains a proinflammatory self-amplifying loop with IL-17C in anti-TNF-induced psoriasiform skin lesions of patients with Crohn's disease. Friedrich M, Tillack C, Wollenberg A, Schauber J, Brand S. Inflamm Bowel Dis; 2014 Nov 01; 20(11):1891-901. PubMed ID: 25299544 [Abstract] [Full Text] [Related]
19. LEKTI domain 6 displays anti-inflammatory action in vitro and in a murine atopic dermatitis model. Canbolat P, Wilzopolski J, Kaessmeyer S, Filor V, Vidak J, Rüger M, Mägert HJ, Forssmann WG, Bäumer W. J Dermatol Sci; 2024 Jul 01; 115(1):13-20. PubMed ID: 38849289 [Abstract] [Full Text] [Related]
20. IL-17A and TNF-α-induced Dectin-1 expression may promote keratinocyte proliferation in psoriatic lesions. Cui W, Liu J, Kong S, Huang H, Liu L, Cao Y, Gu Z. Eur J Dermatol; 2024 Apr 01; 34(2):119-130. PubMed ID: 38907541 [Abstract] [Full Text] [Related] Page: [Next] [New Search]